Skip to main content
Top
Published in: Rheumatology International 9/2020

01-09-2020 | Fibromyalgia | Observational Research

Association between daily level of objective physical activity and C-Reactive protein in a representative national sample of adults with self-reported diagnosed arthritis or fibromyalgia

Authors: Celia Kingsbury, Anthony. D. Karelis, Gabriel Hains-Monfette, Paquito Bernard

Published in: Rheumatology International | Issue 9/2020

Login to get access

Abstract

Purpose

Examine the association between physical activity and sedentary time with high sensitivity C-Reactive protein levels in adults with arthritis and fibromyalgia. We also investigated the dose of physical activity that was associated with lower clinical levels of high sensitivity C-Reactive protein (< 3 mg/L).

Materials and methods

Observational design was used to evaluate the variables of interest-based on the Canadian Health Measures Survey cycle 1–3 (2007–2012). Generalized adjusted additive models were used to explore the shape of the association between high sensitivity C-Reactive protein, daily physical activity, step count and sedentary time. High sensitivity C-Reactive protein was measured with blood samples. Physical activity, number of steps and sedentary time were objectively assessed using an Actical accelerometer.

Results

Daily moderate to vigorous physical activity and step count were significantly associated with lower high sensitivity C-Reactive protein levels, but daily light physical activity and sedentary time were not associated with high sensitivity C-Reactive protein levels, even after controlling for age, sex, daily smoking, body mass index, household income, level of education levels, marital status, work year and accelerometer wear time and season of accelerometer. Non-linear dose–response patterns were observed between daily moderate to vigorous physical activity as well as step count with high sensitivity C-Reactive protein levels. Lower high sensitivity C-Reactive protein levels were associated with 1–150 min of daily moderate to vigorous physical activity and with daily step count starting at 4000 in people with arthritis. Adults with fibromyalgia had lower levels of high sensitivity C-Reactive protein when engaging in 10–35 min of daily moderate to vigorous physical activity and in 5000–9000 daily steps. Optimal and specific doses of daily moderate to vigorous physical activity and steps were independently related to lower high sensitivity C-Reactive protein levels in adults with arthritis and fibromyalgia.

Conclusions

Daily moderate to vigorous physical activity and step count were associated with high sensitivity C-Reactive protein levels that were below the clinical threshold. Given the positive outcomes of physical activity on health, adults with arthritis and fibromyalgia may benefit from these specific recommendations.
Literature
10.
go back to reference Bazzichi L, Rossi A, Massimetti G et al (2007) Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 25:225–230PubMed Bazzichi L, Rossi A, Massimetti G et al (2007) Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 25:225–230PubMed
18.
go back to reference Tremblay MS, Gorber SC (2007) Canadian health measures survey: brief overview. Can J Public Health Rev Can Sante Publique 98:453–456CrossRef Tremblay MS, Gorber SC (2007) Canadian health measures survey: brief overview. Can J Public Health Rev Can Sante Publique 98:453–456CrossRef
24.
go back to reference Bryan S, St-Denis M, Wojtas D Canadian Health Measures Survey: Clinic operations and logistics. 18:19 Bryan S, St-Denis M, Wojtas D Canadian Health Measures Survey: Clinic operations and logistics. 18:19
28.
go back to reference Statistics Canada (2010) Quality control and data reduction procedures for accelerometry-derived measures of physical activity. Health Rep 21:63–69 Statistics Canada (2010) Quality control and data reduction procedures for accelerometry-derived measures of physical activity. Health Rep 21:63–69
30.
go back to reference Wood SN (2006) Generalized additive models: an introduction with R. Chapman & Hall/CRC, Boca RatonCrossRef Wood SN (2006) Generalized additive models: an introduction with R. Chapman & Hall/CRC, Boca RatonCrossRef
35.
go back to reference Katapally TR, Muhajarine N (2014) Towards uniform accelerometry analysis: a standardization methodology to minimize measurement bias due to systematic accelerometer wear-time variation. J Sports Sci Med 13:8 Katapally TR, Muhajarine N (2014) Towards uniform accelerometry analysis: a standardization methodology to minimize measurement bias due to systematic accelerometer wear-time variation. J Sports Sci Med 13:8
36.
go back to reference Lumley TS (2010) Complex Surveys: A Guide to Analysis Using R. John Wiley, Hoboken, NJ, USACrossRef Lumley TS (2010) Complex Surveys: A Guide to Analysis Using R. John Wiley, Hoboken, NJ, USACrossRef
Metadata
Title
Association between daily level of objective physical activity and C-Reactive protein in a representative national sample of adults with self-reported diagnosed arthritis or fibromyalgia
Authors
Celia Kingsbury
Anthony. D. Karelis
Gabriel Hains-Monfette
Paquito Bernard
Publication date
01-09-2020
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 9/2020
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-020-04571-y

Other articles of this Issue 9/2020

Rheumatology International 9/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.